Add-on to Micamlo BP Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Hypertension
Interventions
DRUG

Telmisartan + amlodipine

FDC tablet

DRUG

hydrochlorothiazide

tablet

DRUG

Telmisartan + amlodipine

FDC tablet

DRUG

Placebo

placebo matching hydrochlorothiazide tablet

Trial Locations (30)

Unknown

1348.1.015 Boehringer Ingelheim Investigational Site, Atsubetsu-ku,Sapporo,Hokkaido

1348.1.006 Boehringer Ingelheim Investigational Site, Bunkyo-ku, Tokyo

1348.1.002 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

1348.1.005 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

1348.1.031 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

1348.1.030 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

1348.1.033 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

1348.1.016 Boehringer Ingelheim Investigational Site, Chuo-ku,Sapporo,Hokkaido

1348.1.021 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1348.1.024 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

1348.1.028 Boehringer Ingelheim Investigational Site, Itoshima, Fukuoka

1348.1.027 Boehringer Ingelheim Investigational Site, Katsushika-ku, Tokyo

1348.1.001 Boehringer Ingelheim Investigational Site, Kishiwada, Osaka

1348.1.009 Boehringer Ingelheim Investigational Site, Kita-ku, Osaka

1348.1.029 Boehringer Ingelheim Investigational Site, Kita-ku, Osaka

1348.1.014 Boehringer Ingelheim Investigational Site, Kiyose,Tokyo

1348.1.003 Boehringer Ingelheim Investigational Site, Koto-ku, Tokyo

1348.1.022 Boehringer Ingelheim Investigational Site, Mihama-ku, Chiba, Chiba

1348.1.004 Boehringer Ingelheim Investigational Site, Miyagino-ku, Sendai, Miyagi

1348.1.017 Boehringer Ingelheim Investigational Site, Moriya, Ibaraki

1348.1.013 Boehringer Ingelheim Investigational Site, Naka-ku,Yokohama,Kanagawa

1348.1.018 Boehringer Ingelheim Investigational Site, Nishi-ku, Fukuoka, Fukuoka

1348.1.007 Boehringer Ingelheim Investigational Site, Okinawa, Okinawa

1348.1.020 Boehringer Ingelheim Investigational Site, Sakaide, Kagawa

1348.1.025 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1348.1.026 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1348.1.008 Boehringer Ingelheim Investigational Site, Suita, Osaka

1348.1.032 Boehringer Ingelheim Investigational Site, Suita, Osaka

1348.1.019 Boehringer Ingelheim Investigational Site, Takamatsu, Kagawa

1348.1.023 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01975246 - Add-on to Micamlo BP Trial | Biotech Hunter | Biotech Hunter